Abstract
Cancer is a major cause of death both in developed and developing countries. Among the various types of cancers, primary liver cancer represents about 4% of all cancers worldwide. Hepatocellular carcinoma (HCC) is a histological type of liver cancer; the fact being that the aspects related to the development of hepatocellular carcinoma and its metastasis are not yet known, and here animal models play an important role in diagnosis, prognosis, and treatment strategies of the disease. Animal models also provide an opportunity to explore new treatment strategies. N-nitroso compounds mainly N-diethylnitrosamine (DEN) is a hepatic carcinogen, which is well known to cause liver necrosis. The current review is based on research and review of works on animal models treated with DEN-induced hepatocarcinogenesis. Despite ongoing debate, animal models could provide valuable information about biotransformation of toxicants and how they worsen the damaging effects on DNA and cell proteins that result in the development of cancer. Today, the emergence of various therapies that target the immune system and the tumor microenvironment emphasizes the importance of the host, conditions of chronic inflammation, and fibrosis. Thus, the use of animal models for anti-HCC drug screening will find our best ability to successfully discover new drugs to combat HCC.
Similar content being viewed by others
References
Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491
Amin A, Hamza AA, Bajbouj K, Ashraf SS, Daoud S (2011) Saffron: a potential candidate for a novel anticancer drug against hepatocellular carcinoma. Hepatology 54:857–867
Angalammal P, AlSalhi MS, Sivakumari K, Devanesan S, Rajesh S, Tamizhazhagan V (2021) Phytochemical evaluation and anticancer activity of rambutan (Nephelium lappaceum) fruit endocarp extract against human hepatocellular carcinoma (HepG-2) cells. Saudi J Biol Sci 28(3):1816–1825
Balamurugan K, Karthikeyan J (2012) Evaluation of luteolin in the prevention of N-nitrosodiethylamine-induced hepatocellular carcinoma using animal model system. Indian J Clin Biochem 27(2):157–163. https://doi.org/10.1007/s12291-011-0166-7
Balogh J, Victor-III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41–53. https://doi.org/10.2147/JHC.S61146
Bartch H, Montesano R (1984) Relevance of nitrosamines to human cancer. Carcinogenesis 5:1381–1393. https://doi.org/10.1093/carcin/5.11.1381
Bartsch H, Hietanen E, Malaveille C (1989) Carcinogenic nitrosamines: free radical aspects of their action. Free Radic Biol Med 7:637–644. https://doi.org/10.1016/0891-5849(89)90144-5
Chang W, He W, Li PP, Song SS, Yuan PF, Lu JT, Wei W (2016) Protective effects of celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms. Eur J Pharmacol 784:173–180. https://doi.org/10.1016/j.ejphar.2016.04.045
Chuang SE, Kuo ML, Hsu CH (2000a) Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21(2):331–335
Chuang SE, Cheng AL, Lin JK, Kuo ML (2000b) Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38(11):991–995
Darvesh AS, Aggarwal BB, Bishayee A (2012) Curcumin and liver cancer: a review. Curr Pharm Biotechnol 13(1):218–228. https://doi.org/10.2174/138920112798868791
Dhanasekaran M, Baskar AA, Ignacimuthu S, Agastian P, Duraipandiyan V (2009) Chemopreventive potential of epoxy clerodane diterpene from Tinospora cordifolia against diethylnitrosamine-induced hepatocellular carcinoma. Invest New Drugs 27:347–355. https://doi.org/10.1007/s10637-008-9181-9
Ding YF, Peng ZX, Ding L, Peng YR (2019) Baishouwu extract suppresses the development of hepatocellular carcinoma via TLR4/MyD88/NF-κB pathway. Front Pharmacol 10:389. https://doi.org/10.3389/fphar.2019.00389
Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967) OrganotropecarcinogeneWirkungenbei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten [Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats]. Z Krebsforsch 69:103–201
Farber JL, Gerson RJ (1984) Mechanisms of cell injury with hepatotoxic chemicals. Pharmacol Rev 36:71S–75S
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2971
Flora Priyadarshini J, Sivakumari K, Rajesh S, Ashok K, Jayaprakash P (2020) In vitro antioxidant, anticancer and apoptotic potential of green synthesized silver nanoparticles from propolis against human hepatocellular carcinoma (HepG-2) cells. Alochana Chakra J 9(5):801–820
Gey KF (1993) Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 49:679–699
Gowri Shankar K, Vidhya R, Sophy Renilda AJ, Divya S, Ignacimuthu S, Karthick Raja NS, Albin Fleming T (2017) In vitro, in silico and in vivo antitumor activity of crude methanolic extract of Tetilla dactyloidea (Carter, 1869) on DEN induced HCC in a rat model. Biomed Pharmacother 95:795–807
Gupta N, Safhi MM, Nomier Y, Nayeem M, Husain SM, Tripathi P, Agarwal M (2015) Chemoprotective effect of Leucas aspera plant in rats: DEN induced hepatocarcinogenesis. Int J Pharm Sci Rev Res 30(1):22–27
Hamza AA, Heeba GH, Hamza S, Abdalla A, Amin A (2021) Standardized extract of ginger ameliorates liver cancer by reducing proliferation and inducing apoptosis through inhibition oxidative stress/inflammation pathway. Biomed Pharmacother 134:111102
Hemalatha G, Sivakumari K, Rajesh S, Shyamala DK (2020) Phytochemical profiling, the anticancer and apoptotic activity of graviola (Annona muricata) fruit extract against human hepatocellular carcinoma (HepG-2) cells. Int J Zool Appl Biosci 5(1):32–47
Hsu WH, Chang CC, Huang KW, Chen YC, Hsu SL, Wu LC (2015) Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancer. PLoS One 10(4):e0121298. https://doi.org/10.1371/journal.pone.0121298
Janani P, Sivakumari K, Parthasarathy C (2009) Hepatoprotective activity of bacoside A against N-nitrosodiethylamine-induced liver toxicity in adult rats. Cell Biol Toxicol 25:425–434. https://doi.org/10.1007/s10565-008-9096-4
Janani P, Sivakumari K, Geetha A, Yuvaraj S, Parthasarathy C (2010) Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN-induced hepatocellular carcinoma. Cell Biochem Funct 28(2):164–169
Kang JS, Wanibuchi H, Morimura K, Gonzalez FJ, Fukushima S (2007) Role of CYP2E1 in diethylnitrosamine induced hepatocarcinogenesis in vivo. Cancer Res 67:11141–11146
Khan F, Jamal Khan T, Kalamegam G, Pushparaj PN, Chaudhary A, Abuzenadah A, Kumosani T, Barbour E, Al-Qahtani M (2017) Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats. BMC Complement Altern Med 17:418. https://doi.org/10.1186/s12906-017-1926-6
Magee PN, Lee KY (1963) Experimental toxic liver injury by some nitrosamines. Ann N Y Acad Sci 104:916–925
Manimekalai I, Sivakumari K, Ashok K, Rajesh S (2016) Antioxidant and anticancer potential of mangosteen fruit, Garcinia mangostana against hepatocellular carcinoma (HepG-2) cell line. World J Pharm Pharm Sci 5(2):253–293
Nithya V (2021) Indegenous cow ark with Allium sativum – a key to therapeutic and an effective antioxidant to hepatocellular carcinoma. Int J Aquat Sci 12(2):1631–1644
Padmavathy K, Sivakumari K, Karthika S, Rajesh S, Ashok K (2021) Phytochemical profiling and anticancer activity of dragon fruit Hylocereus undatus extracts against human hepatocellular carcinoma cancer (HepG-2) cells. Int J Pharm Sci Res 12(5):2770–2778. https://doi.org/10.13040/IJPSR.0975-8232
Piot HC, Sirica AE (1980) The stage of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 60:191–215
Priya VV, Jainu M, Mohan SK (2018) Biochemical evidence for the antitumor potential of Garcinia mangostana Linn. On diethylnitrosamine-induced hepatic carcinoma. Pharmacogn Mag 14:186–190
Raj SD, Aiyavu C, Vennila JJ, Panneerselvam K (2009) The hepatoprotective effect of alcoholic extract of Annona squamosa leaves on experimentally induced liver injury in Swiss albino mice. IJIB 5(3):182–6
Rajesh S, Sivakumari K (2020) Anticancer activity of isolated fractions from Cardiospermum halicacabum methanol leaf extract on human hepatocellular carcinoma (HepG-2) cells. Indian J Nat Sci 10(62):28286–28293
Rajesh S, Sivakumari K, Ashok K, Abitha AR (2016) Anti-cancer activity of Cardiospermum halicacabum Linn. leaf extracts against hepatocellular carcinoma cell line (HepG-2). World. J Pharm Pharm Sci 5(3):1133–1154
Schmahl D, Preussmann R, Hamperl H (1960) Leberkrebserzeugende Wirkung von Dia¨thylnitrosaminnachoraler Gabe beiRatten. Naturwissenschaften 47:89
Shank RC (1975) Toxicology of N-nitroso compounds. Toxicol Appl Pharmacol 31:729–732. https://doi.org/10.1016/0041-008X(75)90257-4
Simonsen R, Uirji MA (1984) Interpreting the profile of liver function tests in pediatric liver transplants. Clin Chem 30:1607–1610
Sivalokanathan S, Ilayaraja M, Balasubramanian MP (2006) Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem 281:87–93
Spiteller G (1996) Enzymic lipid peroxidation – a consequence of cell injury? Free Radic Biol Med 21:1003–1009. https://doi.org/10.1016/S0891-5849(96)00268-7
Tricker AR, Pfundstein B, Theobald E, Preussman R, Spiegenhalder B (1991) Mean daily intake of volatile N-nitrosamines from foods and beverages in West Germany in 1989–1990. Food Chem Toxicol 29:729–732. https://doi.org/10.1016/0278-6915(91)90180-F
Verma A, Singh D, Anwar F (2018) Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway. Inflamm Pharmacol 26:133–146. https://doi.org/10.1007/s10787-017-0350-3
Verna L, Whysner J, Williams GM (1996) N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther 71:57–81
Yang CS, Yoo JS, Ishizaki H, Hong JY (1990) Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 22:147–159
Ye Y, Song Y, Zhuang J, Wang G, Ni J, Xia W (2019) Anticancer effects of echinacoside in hepatocellular carcinoma mouse model and HepG2 cells. J Cell Physiol 234(2):1880–1888. https://doi.org/10.1002/jcp.27063
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Sivakumari, K., Janani, P., Rajesh, S. (2022). DEN-Induced Hepatocellular Carcinoma in Animal Model. In: Pathak, S., Banerjee, A., Bisgin, A. (eds) Handbook of Animal Models and its Uses in Cancer Research. Springer, Singapore. https://doi.org/10.1007/978-981-19-1282-5_23-1
Download citation
DOI: https://doi.org/10.1007/978-981-19-1282-5_23-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-1282-5
Online ISBN: 978-981-19-1282-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences